[1] |
ZHAO Lingzhi, HE Yanjun, XIE Jianqin, YOU Chongge.
Research progress on therapeutic role of recombinant human soluble thrombomodulin in atherosclerosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 832-840.
|
[2] |
LI Chen-yu, SUN Xiao-hong, WANG li, LI Hua.
Progress in thrombomodulin researches
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 445-449.
|
[3] |
XIN Hua-wen, LIU Hui-ming, LI Yuan-qi, HUANG Hui, ZHAO Li, YU Ai-rong, LI Qing, WU Xiao-chun, LI Wei-liang, XIONG Lei.
Association of ABCC2 genetic polymorphism with liver disfunction induced by cyclosporine in Chinese renal transplant recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(7): 778-784.
|
[4] |
MENG Xiang-guang, NI Wen-qiong, WANG Chao, MA Deng-xuan, LI Zhi, ZHOU Hong-hao.
Advances in pharmacogenetics of systemic therapies for psoriasis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(11): 1307-1313.
|
[5] |
ZHU Su-yan, HU Yi-jiang, CHEN Jiang-fei, XU Ping, LONG Zai-hao.
Effect of licorice extract on cyclosporine pharmacokinetics in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(9): 971-974.
|
[6] |
PENG Hong-jun, JI Hui, DAI De-zai, DAI Yin.
Protective effects of cyclosporine A on myocardial damage and fibrosis induced by isoproterenol via ET pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(9): 966-971.
|
[7] |
SHI Dao-hua, LIN Zhi-jie.
Association between genetic polymorphism of CYP3A5 and blood con-centration/dose ratio of cyclosporine combined with calcium channel blockers in renal transplant patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(10): 1149-1153.
|
[8] |
WU Li-ping, LI Qi-xiong.
Protective effects of quercetin on nephrotoxicity induced by cyclosporine A in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(6): 659-667.
|
[9] |
ZHANG Ya-tong, YANG Li-ping, SHAO Hong, LI Ke-xin, SUN Chun-hua, SHI Lu-wen.
Effects of different formulations of cyclosporine A on trough blood concentration in patients with myasthenia gravis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(8): 871-875.
|
[10] |
ZHANG Ya-tong, YANG Li-ping, SHAO Hong, Li Ke-xin, SUN Chun-hua, SHI Lu-wen.
Effects of MDR1 gene C3435T polymorphism on pharmacokinetics of cyclosporine A in myasthenia gravis patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(2): 133-136.
|
[11] |
DONG Ya-Lin, WANG Mao-Yi, HUANG Meng, TIAN Pu-Xun, PANG Sheng-Qiang.
Clinical use of mycophenolate mofetil in renal taransplation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1999, 4(4): 313-315.
|
[12] |
XU Feng, FAN Li-Pei, WU Zhao-Hui, ZOU Heng-Qing, ZHANG Zhong-Yi.
Application of simvastatin in hyperlipidemic patients after renal transplantation1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1998, 3(4): 246-249.
|
[13] |
ZHANG Li-Ming, ZHU Li-Qing, WU Xiu-Hua.
Effects of Shiquandabu bolus on cyclosporinl induced hepatotoxicity in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1998, 3(3): 192-193.
|
[14] |
Xia Dongya, Zhao Qingchun, Liu Baoqing, Xiang Jun, Liu Long, Wu Qiusheng.
Monitoring of whole blood level of cyclosporine in 3275 samples from 521 renal transplant recipients by specific fluorescence polarization immunoassay
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(4): 256-259.
|
[15] |
Wu Zhaohui, Xu Feng, Zou Hengqin.
Therapeutic drug monitoring of cyclosporine in Kidney-transplanted recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(1): 45-47.
|